Our goal is to support research that seeks to answer the difficult questions in cancer biology. We are looking for innovative and truly novel ideas that have the potential to revolutionize our understanding of cancer and how to beat it.
We award grants to support fundamental or translational research into the prevention, diagnosis or treatment of cancer. We do not prioritize any field of research within this; we welcome research that draws on epidemiological, behavioural and clinical data to provide a starting point for a new avenue of research. Multidisciplinary or discipline-hopping projects are encouraged where this helps stimulate innovation.
Deadlines:
This opportunity is only open to DCI members.
We award project grants from 12 to 36 months in length to principal investigators based at any not-for-profit research institute in the world.
The principal investigator must be a suitably qualified researcher (minimum of PhD followed by three years research experience, or equivalent qualification or research experience).
A research group can only submit a single application to Worldwide Cancer Research in a grant round. For example, if you are the PI on an application in this round, no member of your research group can be PI on a second application. If, at any stage of a grant round, a research group is found to have submitted multiple applications as PIs, all the applications will be rejected immediately and the group may be barred from applying in future. This rule only applies to PIs. You can be PI on one application and a co-applicant or collaborator on other applications at the same time.
The maximum budget allowed is £250,000, but it should be noted that most of the three-year grants we award have a budget below £200,000.
If you are interested in applying for this opportunity, please send the following in 1 PDF to Erin Carr at erin.carr@duke.edu no later than 5:00pm on Friday, April 19th.
* Title of the proposed research project
* Brief description of the research proposal
* Brief statement of applicant’s eligibility
